However, returning appetite and reduced fullness signals may cause hunger, food cravings, and rapid weight regain, which can feel psychologically challenging
Recent research shows that the effects of GLP-1 medication end shortly after patients stop taking the medication
Although these studies are published in indexed journals, independent replication by other research groups remains insufficient to draw definitive conclusions about therapeutic efficacy in humans
Thus, in endothelial cells exposed to chronic hyperglycemia, sitagliptin treatment for 3 weeks decreased ROS production, 41 while in animal model, sitagliptin antitumoral effects were mediated via ROS inhibition
Protudjer, University of Manitoba, Canada Karin Pfisterer, Medical University of Vienna, Austria Updates Copyright 2024 De Simoni, Candelora, Belleggia, Rizzetto, Molinelli, Capodaglio, Ferretti, Bacchetti, Offidani and Simonetti